Broadly Neutralizing Antibodies Venom Research Influenza Monoclonal Antibodies Protein Engineering Snake Venom Research Neutralizing Antibodies Antivenom Research Venom Immunization Antivenom Development Allergen-Specific Therapy Therapeutics Cross-Reactivity Llama Antibodies Vaccine Development
Phase 1/2 safety trials in human newborns are being planned after primate studies showed durable HIV protection, with researchers addressing immunogenicity, strain diversity, production scalability.